Trials / Withdrawn
WithdrawnNCT00771797
Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment
Clinical Study to Assess the Clinical Efficacy of Flavanol-rich Cocoa on Vascular Function in Diabetic Patients With PAOD
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- RWTH Aachen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the clinical efficacy and to simultaneously explore the underlying molecular mechanisms of the beneficial effects of flavanol-rich cocoa on vascular function diabetic patients with peripheral artery occlusive diseases (PAOD) of the lower extremities will be investigated.
Detailed description
50 Type 2 diabetics according to the criteria of the American Diabetes Association suffering from PAOD with a pain free walking distance less than 200 m will be enrolled. In a randomized controlled parallel group study the before established novel 5-level approach of vascular diagnostics will be realised. In order to test the hypothesis, whether cocoa rich in flavanols improves vascular function of diabetic PAOD subjects will regularly intake flavanol rich cocoa (group 1: 975 mg/d, n=50 versus group 2: 90 mg/d, n=50) over a period of two months. Clinical endpoints are the Ankle-Brachial-Index, measured by Doppler ultrasound and the pain-free walking distance determined by a treadmill ergometer. All parameters of vascular diagnostic (see 5-level approach above) will be determined before and two month after cocoa ingestion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | high dose flavanoids | flavanoid rich cocoa 2 times daily over 60 days |
| DIETARY_SUPPLEMENT | low dose flavanoids | treatment with flavanoid-low cocoa two times daily over 60 days |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-10-13
- Last updated
- 2015-09-23
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00771797. Inclusion in this directory is not an endorsement.